In News Posted
The VALIDATE Network
The VALIDATE Network aims to accelerate vaccine development for globally significant diseases caused by complex neglected intracellular pathogens. Our initial focus is on TB, leishmaniasis, [...]
In Uncategorized Posted
World TB Day 2019: It’s time! … to strengthen collaborative Research & Innovation partnerships in TB vaccines
True to the World Tuberculosis Day 2019 theme ‘It’s time!’ TBVI continues its efforts to sustain its unique collaborative research infrastructure with the aim to develop new, effective, [...]
In Uncategorized Posted
2019 TBVI Symposium “TB Vaccines: Global Collaboration and Recent Advances in the Field”.
From 28th to 31st January 2019 in Les Diablerets Switzerland, the TBVI symposium and TBVAC2020 annual meeting brought together 120 scientists and policy makers from 70 research institutes, [...]
In Uncategorized Posted
STriTuVaD consortium meeting lays down the foundations for a fruitful EU-India cooperation in the fight against Tuberculosis
STriTuVaD, a EC Horizon2020 project, held its inauguration and investigators meeting in New Delhi, India on 23 January in the presence of Indian and European authorities. Please read the press [...]
In Uncategorized Posted
Alternative vaccination route protects against tuberculosis
A different approach to vaccination could stop hypersensitive rhesus monkeys from developing tuberculosis (TB). Researchers from the Biomedical Primate Research Centre (BPRC) have demonstrated [...]